as on February 9, 2026 at 9:31 pm IST
Day's Low
Day's High
6.56%
Downside
0.58%
Upside
52 Week's Low
52 Week's High
13.64%
Downside
68.07%
Upside
as on February 9, 2026 at 4:01 pm IST
Market Cap
₹1,124.83 Cr
Return on Equity (ROE)
18.58
PE Ratio (TTM)
0Return on capital employed (ROCE)
22.82
Beta (LTM)
1.41
P/B Ratio
5.99
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-65.77
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Neutral
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Jagsonpal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,124.83 | 85.89% | 0.00 | 55 | 268 | |
| NA | 227.18 | 110.2% | 0.00 | 2 | 386 | |
| NA | 36.13 | -10.12% | 0.00 | 4 | 82 | |
| BUY | 29,689.57 | 51.01% | 0.51 | 659 | 3,917 | |
| NA | 626.60 | 60.42% | 0.60 | 24 | 198 |
Get share price movements and forecasts by analysts on Jagsonpal Pharma .
Source: S&P Global Market Intelligence
Search interest for Jagsonpal Pharmaceuticals Ltd Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Jagsonpal Pharma .
Jagsonpal Pharmaceuticals Ltd’s net profit fell -65.77% since last year same period to ₹10.95Cr in the Q3 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -12.89% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 06 May 2025 - translating a dividend yield of 4.46%.
Read More about DividendsCheck stock indices that include Jagsonpal Pharma .
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 30.25% to 30.34% in Dec 2025 quarter
FII Holding Unchanged
![]()
Foreign Institutions holdings remained unchanged at 2.12% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 6 months, JAGSNPHARM stock has moved down by -32.6%
Promoter Holding Down
![]()
Promoters have decreased holdings from 67.54% to 67.39% in Dec 2025 quarter
| Organisation | Jagsonpal Pharmaceuticals Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Harsha Raghavan |
| E-voting on shares | Click here to vote |
Jagsonpal Pharma share price today stands at ₹179.48 as on at the close of the market. Jagsonpal Pharma share today touched a day high of ₹180.52 and a low of ₹167.7.
Jagsonpal Pharma touched a 52 week high of ₹301.65 and a 52 week low of ₹155. Jagsonpal Pharma share price today i.e. is closed at ₹179.48, which is -40.50% down from its 52 week high and 15.79% up from its 52 week low.
Jagsonpal Pharma market capitalisation is ₹1,124.83 Cr as on .
To buy Jagsonpal Pharma shares, you need to follow these steps:
Jagsonpal Pharma trading volume is 61.47K as on . This means that 61.47K shares of Jagsonpal Pharma were bought and sold on the stock market during today's trading session.